Biogen is dropping controversial Alzheimer’s drug Aduhelm
Jan 31, 2024
Biogen said it will shift its focus to a newer Alzheimer’s drug, Leqembi, which it markets in a partnership with Japan-based Eisai. Leqembi received FDA approval last year.
Where dementia is most prevalent
By
Lois A. Bowers
Feb 03, 2016
A new tool from the federal government provides county- and state-level prevalence data for Alzheimer’s/dementia and 15 other chronic conditions.
More news for Tuesday, Feb. 7
Feb 06, 2017
Search for Alzheimer’s drugs is more urgent than ever … How would Republican plans for Medicaid block grants actually work? … Long-term care advocates call on Canadian government to invest...
Medicare mulls coverage for controversial drug for Alzheimer’s disease
Jul 13, 2021
CMS says a final decision on coverage is not likely until next spring.
Medicare will cover new class of Alzheimer’s drugs if fully approved by FDA, with limits
Jun 02, 2023
Drug makers also will have to gather and keep data in a registry showing how the drugs are working in the real world.
Medicare monthly premiums to drop for seniors
Sep 28, 2022
The fee cuts come at the same time as seniors receive a Social Security cost-of-living increase for 2023 of up to 9 or 10%.
NCBAC Alzheimer Caregiver Guide approved for Florida direct-care workers
Feb 22, 2016
The state of Florida now recognizes the National Certification Board for Alzheimer Care’s Alzheimer Caregiver Guide to meet the four-hour training requirement for direct care workers in assisted...
Medicare may rethink premium hike for pricey Alzheimer’s drug
Jan 10, 2022
The announcement comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to $28,000 a year.
CCAs can lower person-centered dementia care costs
By
Lois A. Bowers
Apr 10, 2016
Care coordinator assistants can be a low-cost way to facilitate person-centered care for those with dementia and their caregivers, according to a new study.
CMS officially removes one-time restriction for Alzheimer’s PET scan coverage
By
Aaron Dorman
Oct 17, 2023
Seniors covered by Medicare will now have expanded access to Alzheimer’s diagnostic PET scans after the CMS removed one-time restrictions.